Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Thyroid Neoplasms × Nivolumab × Clear all

Status

Sponsor Class

Study Type

Interventional 4 Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 13 Melanoma 11 Head and Neck Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Lung Neoplasms 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Gastrointestinal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Hepatocellular 2 Thyroid Neoplasms 1 Skin Neoplasms 1 Sexual Dysfunction, Physiological 1 Recurrent Squamous Cell Lung Carcinoma 1 Recurrence 1 Oropharyngeal Neoplasms 1 Neoplasms, Squamous Cell 1 Motor Activity 1 Lung Squamous Cell Carcinoma Stage IV 1 Locally Advanced Melanoma 1 Locally Advanced Gastric Cancer 1 Liver Diseases 1 Kidney Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Eunuchism 1 Esophageal Neoplasms 1 Erectile Dysfunction 1 Efficacy, Team 1 Dysplastic Nevus Syndrome 1

Interventions

Thyroidectomy 5 Iodine-131 5 lenvatinib 2 anlotinib 2 Ultrasonography 2 Surgical Procedures, Operative 2 Sorafenib 2 Interviews as Topic 2 Focus Groups 2 Biopsy, Fine-Needle 2 trastuzumab deruxtecan 1 trametinib 1 selpercatinib 1 pralsetinib 1 pembrolizumab 1 gallium Ga 68 dotatate 1 dabrafenib 1 Triiodothyronine 1 Transurethral Resection of Prostate 1 Thyroxine 1 Thyrotropin Alfa 1 Surveys and Questionnaires 1 Routinely Collected Health Data 1 Nivolumab 1 Molecular Diagnostic Techniques 1 Minimally Invasive Surgical Procedures 1 Lymph Node Excision 1 Iodine-124 1 Iodine-123 1 Immunohistochemistry 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07419932 2026-02-19

NeoLATC

Fujian Medical University

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡